Guillermo Rodriguez-Nava (guiro)
banner
grod11.bsky.social
Guillermo Rodriguez-Nava (guiro)
@grod11.bsky.social
Infectious Diseases physician | Hospital Epidemiologist | Denver Health (Hospital) and University of Colorado | USA ESCMID Local Champion | Passionate about diagnostic stewardship, molecular epi, and AI
You can also revisit our poster with great colleagues at the Veterans Affairs Health System! We analyzed 24-year national trends of resistant Enterobacterales and Pseudomonas in urine cultures from spinal cord injury patients. Proud of those maps I coded myself 😜 #IDWeek2025
October 22, 2025 at 2:54 PM
If you’re still around at #IDWeek2025, stop by poster 1967! If not, here it is — a workflow using LLMs on real patient data showed limited performance compared to an ID expert in adjudicating blood culture appropriateness.

Check out our CLABSI paper: pmc.ncbi.nlm.nih.gov/articles/PMC...
October 22, 2025 at 2:40 PM
If you’re feeling sad that #IDWeek is coming to an end tomorrow, don’t worry, ESCMID Global is just around the corner! Abstract submissions are now open. It’s such a wonderful conference where I’ve met friends and collaborators from all over the world!

www.escmid.org/congress-eve...
October 21, 2025 at 3:08 PM
Reposted by Guillermo Rodriguez-Nava (guiro)
This study evaluated oral vancomycin primary prophylaxis effectiveness in preventing C. difficile infection (CDI) in BMT patients. Bayesian Meta-analysis showed reduced CDI incidence during hospitalization. We present an innovative approach to adjust for publication bias. doi.org/10.1017/ash....
A systematic literature review and bayesian meta-analysis of oral vancomycin primary prophylaxis for Clostridioides difficile infection in stem cell transplant patients | Antimicrobial Stewardship & Healthcare Epidemiology | Cambridge Core
A systematic literature review and bayesian meta-analysis of oral vancomycin primary prophylaxis for Clostridioides difficile infection in stem cell transplant patients - Volume 5 Issue 1
doi.org
October 15, 2025 at 9:01 PM
Just realized — this is my first talk as a newly minted attending and hospital epidemiologist! Grateful to the Mile High APIC chapter for the opportunity!
October 10, 2025 at 11:18 PM
Excited to share the podium with colleagues, collaborators, and my academic grand-mentor while presenting on AI in healthcare epidemiology at the APIC Mile High Colorado Chapter!
October 9, 2025 at 10:03 PM
Couldn’t agree more! The criteria also fail to keep up with emerging molecular diagnostics, leading to unfair penalties!
October 8, 2025 at 5:11 PM
Colegas en México 🇲🇽: ESCMID busca campeones locales para difundir conocimiento en enfermedades infecciosas. Gran oportunidad para representar a México, unirse a grupos de trabajo internacionales y crecer profesionalmente.

👉 Postúlate aquí: www.escmid.org/about-us/net...
ESCMID Local Champions
ESCMID Local Champions are dedicated experts and advocates for ESCMID, making a significant impact in the fields of CM and ID.
www.escmid.org
October 2, 2025 at 1:10 PM
Denver Health is hiring: Medical Director of Antimicrobial Stewardship & ID physician (musculoskeletal + inpatient consults).

IDSA Center of Excellence • 525-bed hospital • Univ. of Colorado training site.

Details: denverhealth.wd1.myworkdayjobs.com/DHHA-Main/jo... — connect at #IDWeek!
September 17, 2025 at 6:46 PM
Reposted by Guillermo Rodriguez-Nava (guiro)
📣Open call
ESCMID is creating a brand-new #Vaccines Subcommittee. 💉

We are looking for a director to establish this new subcommittee including defining the strategic directives. Interested persons can review the call document: www.escmid.org/about...

#IDSky #MedSky #clinmicro
July 15, 2025 at 8:46 AM
Couldn’t ask for a better way to close out my trainee years than highlighting our work at #SHEASpring2025 — from idea generation to funding, to grabbing wastewater and running tests. Learned epi, IPC, comms, and more! Thanks to @jlsalinas.bsky.social for being the best mentor I could ask for!
April 30, 2025 at 8:52 PM
Reposted by Guillermo Rodriguez-Nava (guiro)
Proud of @grod11.bsky.social he gave two oral presentations on his molecular and wastewater-based hospital epidemiology work at #SheaSpring2025 @stanfordmedicine.bsky.social
April 29, 2025 at 12:53 PM
Reposted by Guillermo Rodriguez-Nava (guiro)
@grod11.bsky.social talking about long-read WGS to discern pre/post contact precautions of transmission of VRE in blood 👏🏻👏🏻👏🏻 #SHEASpring2025
April 28, 2025 at 9:15 PM
Excited to be appointed as the ESCMID Local Champion for the U.S. for the next three years! After many rewarding experiences, I look forward to promoting ESCMID Global and championing infectious diseases—especially the often-overlooked field of healthcare epidemiology!
March 11, 2025 at 12:23 AM
Facing the blood culture shortage, we implemented an order alert and restricted repeat cultures within 72 hours to high-yield indications. Spearheaded by our incredible micro lab and supported by our 2-year stewardship initiative, details here:

doi.org/10.1128/jcm....
January 27, 2025 at 1:23 PM
Reposted by Guillermo Rodriguez-Nava (guiro)
🆕💫Large scale multicenter study in US
BC use was associated with unit type, hospital bed size & region
Highest bld cx use: Medical ICUs
Single blood culture & positive blood culture rates were below 10% across all 4 unit types( medical/surgical ICU/Ws) #idsky #EMIMCC
jamanetwork.com/journals/jam...
Blood Culture Use in Medical and Surgical Intensive Care Units and Wards
This cross-sectional study describes blood culture use in US hospital intensive care units and wards.
jamanetwork.com
January 15, 2025 at 4:45 PM
Up to 79% of providers order blood cultures without evaluating the patient first—lots of room to improve! Honored to collaborate on this national study, led by Johns Hopkins, exploring blood culture practices across 8 US academic institutions.

doi.org/10.1017/ice....
December 20, 2024 at 10:27 PM
Reposted by Guillermo Rodriguez-Nava (guiro)
@jlsalinas.bsky.social loving these approaches to test LLMs for IP&C! Very straightforward and very detailed. Love the supplement info
December 18, 2024 at 3:56 PM
Reposted by Guillermo Rodriguez-Nava (guiro)
🆕 LLM for IP&C Inquiries:

Authors investigated four LLM AI tools’ accuracy. Most provided acceptable answers to IP&C questions. Their use to supplement IP&C consults should be further explored.

@kbrustepi.bsky.social, @grod11.bsky.social, @jlsalinas.bsky.social #IDSky

📄: doi.org/10.1017/ice....
December 18, 2024 at 2:39 PM
Bayesian reasoning is fun.
December 15, 2024 at 3:23 AM
LLMs won’t take our jobs, but learning to work with them is the future. And no, not all LLMs are made equal! In this great collaboration, we tested LLMs for helping infection preventionists—GPT-4 outshined GPT-3.5, Microsoft Copilot, and OpenEvidence @jlsalinas.bsky.social

doi.org/10.1017/ice....
December 12, 2024 at 3:25 PM
Welcome to the new Stanford Infectious Disease fellowship class! Excited for you to learn, grow, and have fun in Silicon Valley
December 5, 2024 at 1:09 AM
Reposted by Guillermo Rodriguez-Nava (guiro)
The readability of scientific articles went down over time.

Should we thank "sounding important for the journal" for this trend?

Or deeper niche-specialization?

📄Source:
https://buff.ly/4hj40HI
November 18, 2024 at 4:00 AM
Honored to be part of the Stanford Health Care team recognized with the Malinda Mitchell Award for Quality. Through collaboration, including blood culture stewardship I led with great support from @jlsalinas.bsky.social and others, we made a real impact on reducing CLABSI. Proud of our team’s work!
November 15, 2024 at 4:18 PM
A picture is worth a 1000 words! My biggest pet peeve? Slides with a 1000 and zero images.

Pro tip: I use ChatGPT to create visuals for my talks—no coding skills needed most of the time. Occasionally, I do need to tweak the code to improve the images!
November 14, 2024 at 5:31 PM